Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Contact us

Our address is: Rue d’Édimbourg 26, 1050 Brussels, Belgium.

Tel: +32 (0)2 893 0930

For media inquiries please contact: media at corporateeurope.org

For any other issues, please use the webform below to contact us or the email address: ceo at corporateeurope.org

Enter your first name.
Leave this field blank, otherwise our system will think you are non-human.
Enter your last name.
Enter your email address so that we can get back to you
Enter your message in the field above.
 
 

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

The voice of the Dutch Government has been loud and clear in Brussels on the issue of cisgenic plants. The Dutch have waged a sustained campaign to have new GM techniques – and in particular cisgenesis – excluded from EU GMO regulations. Several Dutch ministries, the Dutch Parliament, the Dutch Permanent Representation in Brussels, and Dutch MEPs have energetically pursued this goal.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate